Sherbrooke Park Advisers’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $544K | Buy |
5,066
+1,288
| +34% | +$138K | 0.24% | 145 |
|
|
2025
Q1 | $381K | Sell |
3,778
-4,933
| -57% | -$498K | 0.18% | 214 |
|
|
2024
Q4 | $778K | Buy |
8,711
+5,385
| +162% | +$481K | 0.25% | 102 |
|
|
2024
Q3 | $279K | Buy |
+3,326
| New | +$279K | 0.06% | 602 |
|
|
2024
Q1 | – | Sell |
-21,545
| Closed | -$1.25M | – | 845 |
|
|
2023
Q4 | $1.25M | Buy |
21,545
+1,137
| +6% | +$65.7K | 0.59% | 20 |
|
|
2023
Q3 | $1.08M | Sell |
20,408
-18,738
| -48% | -$989K | 0.34% | 94 |
|
|
2023
Q2 | $2.12M | Buy |
39,146
+24,446
| +166% | +$1.32M | 1.11% | 3 |
|
|
2023
Q1 | $735K | Buy |
+14,700
| New | +$735K | 1.11% | 14 |
|